Alves F H F, Crestani C C, Resstel L B M, Corrêa F M A
Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Brain Res. 2007 Apr 27;1143:161-8. doi: 10.1016/j.brainres.2007.01.057. Epub 2007 Jan 25.
The bed nucleus of stria terminalis (BST) has been reported to be involved in central cardiovascular control in rat. We presently report on the cardiovascular effects of carbachol (CBH) microinjection into the BST as well as on local receptor and peripheral mechanisms involved in their mediation. Microinjection of CBH (0.1 to 3 nmol/100 nL) into the BST of anesthetized rats caused dose-related pressor and bradycardiac responses. The cardiovascular response evoked by 1 nmol of CBH was blocked by local microinjection of the nonselective muscarinic receptor antagonist atropine (3 nmol) or the selective M(2)-muscarinic receptor antagonist 4-DAMP (2 nmol). Microinjection of the selective M(1)-muscarinic receptor antagonist pirenzepine (6 nmol) did not affect cardiovascular responses to CBH, suggesting their mediation by local BST M(2)-muscarinic receptors. Cardiovascular responses to CBH microinjected in the BST were markedly reduced in urethane-anesthetized rats. The pressor response was potentiated by i.v. pretreatment with the ganglion blocker pentolinium (10 mg/kg) and blocked by i.v. pretreatment with the vasopressin antagonist dTyr(CH2)5(Me)AVP (50 microg/kg), suggesting involvement of circulating vasopressin in response mediation. In conclusion, results suggest that microinjection of CBH in the BST activates local M(2)-muscarinic receptor evoking pressor and bradycardiac responses, which are mediated by acute vasopressin release into circulation.
据报道,终纹床核(BST)参与大鼠的中枢心血管控制。我们目前报告了向BST微量注射卡巴胆碱(CBH)的心血管效应,以及参与其介导的局部受体和外周机制。向麻醉大鼠的BST微量注射CBH(0.1至3 nmol/100 nL)会引起剂量相关的升压和心动过缓反应。1 nmol CBH引起的心血管反应被局部微量注射非选择性毒蕈碱受体拮抗剂阿托品(3 nmol)或选择性M(2)-毒蕈碱受体拮抗剂4-DAMP(2 nmol)阻断。微量注射选择性M(1)-毒蕈碱受体拮抗剂哌仑西平(6 nmol)不影响对CBH的心血管反应,表明其通过局部BST M(2)-毒蕈碱受体介导。在氨基甲酸乙酯麻醉的大鼠中,对BST微量注射CBH的心血管反应明显降低。静脉注射神经节阻滞剂喷托铵(10 mg/kg)预处理可增强升压反应,而静脉注射血管加压素拮抗剂dTyr(CH2)5(Me)AVP(50 μg/kg)预处理可阻断升压反应,表明循环血管加压素参与反应介导。总之,结果表明,在BST中微量注射CBH会激活局部M(2)-毒蕈碱受体,引发升压和心动过缓反应,这是由血管加压素急性释放到循环中介导的。